- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04957745
Understanding Visual Confusion Using Stereoscopic Displays
Monocular Visual Confusion for Field Expansion
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Schepens Eye Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Better than 20/40 visual acuity in the worse eye
- No restrictions of the peripheral visual field: (at least 60 degrees vertically and 40 degrees horizontally)
- At least 14 years of age (no upper age limit)
- Able to give voluntary, informed consent
- Able to understand English
- Binocular vision parameters within normal limits (Stereopsis ≤ 100 arc sec on any stereo test)
Exclusion criteria:
- Patients with any physical or mental disabilities, including cognitive dysfunction, balance problems, or other deficits that could impair their ability to respond to the stimuli presented in this study will be excluded
- Being unable to complete sessions lasting 2-3 hours
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Visual confusion
Participants viewed peripheral targets in three different visual confusion conditions (three interventions): binocular visual confusion (unilateral opaque target), unilateral monocular visual confusion (unilateral see-through target), and bilateral monocular visual confusion (bilateral see-through target).
Each intervention was presented twice in a randomized order, resulting in a total of six trials.
During each trial, a peripheral target was presented in front of a forward-moving background for one minute.
Participants were instructed to hold down the controller button while the target was visible and release it when a third or more of the target disappeared.
After each trial, participants could take a brief break before the next trial in a different visual confusion condition was presented in a randomized order.
|
The peripheral target was a horizontally drifting grating measuring 10° by 10°, with a spatial frequency of 1 cycle per degree and a temporal frequency of 3 Hz, and located at 10° above the fixation. For the binocular visual confusion condition, the non-transparent (opaque) peripheral target will be displayed on only one eye (unilateral opaque display). The peripheral target was a horizontally drifting grating measuring 10° by 10°, with a spatial frequency of 1 cycle per degree and a temporal frequency of 3 Hz, and located at 10° above the fixation. For the unilateral monocular visual confusion condition, the half-transparent peripheral target will be displayed on only one eye (unilateral see-through display). The peripheral target was a horizontally drifting grating measuring 10° by 10°, with a spatial frequency of 1 cycle per degree and a temporal frequency of 3 Hz, and located at 10° above the fixation. For bilateral monocular visual confusion condition, the half-transparent peripheral target will be displayed on both eyes (bilateral see-through display). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Total Viewing Time That Peripheral Target is Perceived
Time Frame: Approximately 1-2 sessions to finish total 6 trials, up to 2 hours for each session, any time within the 4month study period
|
(Total time the peripheral target in the visual confusion condition was visible) / (total viewing time (=1 min))
|
Approximately 1-2 sessions to finish total 6 trials, up to 2 hours for each session, any time within the 4month study period
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: JaeHyun Jung, Schepens Eye Research Institute
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021P001757
- R01EY031777 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diplopia
-
Fondation Ophtalmologique Adolphe de RothschildRecruiting
-
Mount Sinai Hospital, CanadaCompleted
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
National University Hospital, SingaporeUnknownFractures | Diplopia | EnophthalmosSingapore
-
College of Medical Sciences, BharatpurCompletedNeurologic ManifestationsNepal
-
University Hospital, Strasbourg, FranceCompletedMRI | Stroke | Dizziness | Diplopia | Emergency DepartmentFrance
-
AO Innovation Translation CenterActive, not recruitingOrbital Fractures | Blow Out Fracture of OrbitUnited States, Sweden, Qatar, South Africa, Switzerland, Netherlands, Spain, Germany, Serbia, Pakistan, Romania, Russia
-
THYROSCOPE INC.Not yet recruitingThyroid Eye Disease | Strabismus | Ocular Motility Disorders | Extraocular Muscle DysfunctionUnited States
Clinical Trials on Binocular visual confusion (unilateral opaque)
-
Texas Christian UniversityEnrolling by invitation
-
State University of New York College of OptometryNational Eye Institute (NEI); Nova Southeastern University; University of Maryland...Unknown
-
Riphah International UniversityActive, not recruitingStroke | Rehabilitation | Gait BalancePakistan
-
University of Modena and Reggio EmiliaUnknownDementia | Cataract | Cataract Senile | Mild Cognitive Impairment | Post-Op Complication | Delirium in Old Age | Delirium Confusional State | Cataract in Old AgeItaly
-
Essilor InternationalCompletedPresbyopia | Near Vision | Refraction ErrorFrance